Cargando…

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban

Detalles Bibliográficos
Autores principales:	Guetl, Katharina, Gary, Thomas, Raggam, Reinhard B, Schmid, Johannes, Wölfler, Albert, Brodmann, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Clinical Picture
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195494/ https://www.ncbi.nlm.nih.gov/pubmed/34126043 http://dx.doi.org/10.1016/S0140-6736(21)01238-1

Ejemplares similares

Thrombotic Complications after COVID-19 Vaccination: Diagnosis and Treatment Options
por: Guetl, Katharina, et al.
Publicado: (2022)

Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
por: Gattringer, Thomas, et al.
Publicado: (2021)

Argatroban/azd-1222/dexamethasone: Thrombotic thrombocytopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

The White Blood Cell Count to Mean Platelet Volume Ratio for the Prediction of Chronic Limb-Threatening Ischemia in Lower Extremity Artery Disease
por: Guetl, Katharina, et al.
Publicado: (2019)

Argatroban for heparin-induced thrombocytopenia therapy in ICU patients with sepsis or multiple organ dysfunction syndrome
por: Saugel, B, et al.
Publicado: (2009)

Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2010)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021)

Papilledema due to Vaccine-Induced Thrombocytopenia
por: Qian, Jenn, et al.
Publicado: (2022)

Significant increase in the incidence of high-risk pulmonary embolism during the COVID-19 shutdown: The pandemic response causes serious collateral consequences
por: Gressenberger, Paul, et al.
Publicado: (2020)

Correction: Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2012)

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
por: Colarossi, Giorgia, et al.
Publicado: (2021)

Argatroban/immunostimulants: Vaccine-induced immune thrombotic thrombopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
por: Brodmann, Marianne, et al.
Publicado: (2022)

In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia
por: Nygaard, Søren, et al.
Publicado: (2023)

Complete Thrombotic Occlusion of the Abdominal Aorta
por: Kamano, Shumpei, et al.
Publicado: (2022)

Severe Fever with Thrombocytopenia Syndrome
por: Taniguchi, Tomohiro, et al.
Publicado: (2016)

Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia
por: Marchetti, Matteo, et al.
Publicado: (2022)

Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis
por: Gressenberger, Paul, et al.
Publicado: (2022)

Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients
por: Kim, Young Su, et al.
Publicado: (2018)

Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia and Renal Insufficiency Undergoing Orthotopic Heart Transplantation
por: Green, Michael Stuart, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia
por: Liu, Yumei, et al.
Publicado: (2022)

Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
por: Abdelsamia, Mahmoud, et al.
Publicado: (2023)

Successful Management of Heparin-Induced Thrombocytopenia Using Argatroban in a Very Old Woman: A Case Report
por: Putot, A., et al.
Publicado: (2013)

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?
por: Nakagawa, Tetsuya
Publicado: (2008)

The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients
por: Rief, Peter, et al.
Publicado: (2016)

Immune Thrombocytopenia and Cerebral Hemorrhaging Associated with COVID-19
por: Hayashi, Koken, et al.
Publicado: (2021)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

Low mean platelet volume is associated with critical limb ischemia in peripheral arterial occlusive disease
por: Rief, Peter, et al.
Publicado: (2018)

Hyperthyroidism with Selective Immunoglobulin A Deficiency
por: Harada, Ko, et al.
Publicado: (2018)

Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
por: Bayas, Antonios, et al.
Publicado: (2021)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021)

Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f09fa2gbbpjos7hv1fili9ijd5